Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

5< - Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy

Joseph C. Blader, Nina R. Schooler, Peter S. Jensen, Steven R. Pliszka, and Vivian Kafantaris

Am J Psychiatry 2009; 166:1392-1401

5 - Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

Randall Owen, Linmarie Sikich, Ronald N. Marcus, Patricia Corey-Lisle, George Manos, Robert D. McQuade, William H. Carson, and Robert L. Findling

PEDIATRICS Vol. 124 No. 6 December 2009, pp. 1533-1540 (doi:)

 

3 - Dexmethylphenidate Extended Release: A Review of its Use in the Treatment of Attention-Deficit Hyperactivity Disorder

Moen, Marit D; Keam, Susan J

CNS Drugs: 1 December 2009 - Volume 23 - Issue 12 - pp 1057-1083

 

3 - Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

Shella Schirman, Sefi Kronenberg, Alan Apter, David Brent, Nadine Melhem, Nimrod Pick, Miri Carmel, Amos Frisch, Abraham Weizman and Doron Gothelf

Journal of Neural Transmission. Volume 117, Number 1 / January, 2010: 139-145

 

3 - A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents

Swadi, Harith S; Craig, Brian J; Pirwani, Nabeel Z; Black, Valerie C; Buchan, Jill C; Bobier, Candace M

International Clinical Psychopharmacology: January 2010 - Volume 25 - Issue 1 - pp 1-6

 

GRATIS 3 - Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient  onsiderations and the role of lisdexamfetamine

Brian J Cowles

Therapeutics and Clinical Risk Management. December 2009 , Volume 2009:5

 

3 - Serum Concentrations, Therapeutic Response and Side Effects in Children and Adolescents with Impulsive-Aggressive Symptoms during Risperidone Therapy

K. Klampfl, R. Taurines, A. Preuss, R. Burger, S. Rothenhöfer, Ch. Wewetzer, B. Pfuhlmann, J. Fegert, M. Gerlach, C. Mehler-Wex

Pharmacopsychiatry. Dec 2009

3! - Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia

Anand Mattai, Alex Chavez, Deanna Greenstein, Liv Clasen, Jennifer Bakalar, Reva Stidd, Judith Rapoport and Nitin Gogtay

Schizophrenia Research. Volume 116, Issue 1, January 2010, Pages 44-48

 

GRATIS 3 - Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

Oscar G Bukstein, L Eugene Arnold, Jeanne M Landgraf and Paul Hodgkins

Child and Adolescent Psychiatry and Mental Health 2009, 3:39

 

5 - Atomoxetine Versus Stimulants in the Community Treatment of Children With ADHD. An Electronic Diary Study

Carol K. Whalen, Barbara Henker, Sharon S. Ishikawa, Natasha A. Emmerson, Ralph Swindle, Joseph A. Johnston

Journal of Attention Disorders, Vol. 13, No. 4, 391-400 (2010)

3! - Predicting Response of ADHD Symptoms to Methylphenidate Treatment Based on Comorbid Anxiety

Brittany Blouin, Cindy Maddeaux, Jill Stanley Firestone, Judy van Stralen

Journal of Attention Disorders, Vol. 13, No. 4, 414-419 (2010)

 

3! - Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.

Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS, Abreu RL, Oliveira GG, Vicente AM

Pharmacogenomics J. 2009 Dec 8. [Epub ahead of print]

 

GRATIS 3! - Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia

Calvin R Sumner, Susan Gathercole, Michael Greenbaum, Richard Rubin, David Williams, Millie Hollandbeck and Linda Wietecha

Child and Adolescent Psychiatry and Mental Health 2009, 3:40

 

5 - A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome

J Jankovic, J Jimenez-Shahed, L W Brown

J Neurol Neurosurg Psychiatry 2010;81:70-73

 

3 - Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

Garnock-Jones, Karly P; Keating, Gillian M

CNS Drugs: 1 January 2010 - Volume 24 - Issue 1 - pp 85-88

 

3 - Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder

Yoo HK, Park S, Wang HR, Lee JS, Kim K, Paik KW, Yum MS, Ko TS

Epileptic Disord. [Epub ahead of print]

 

5 - A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia

Magali Haas, Alan S. Unis, Jorge Armenteros, Margaret D. Copenhaver, Jorge A. Quiroz, Stuart F. Kushner

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 611-621

 

3 - Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study

Gholson J. Lyon, Stephanie Samar, Rahil Jummani, Scott Hirsch, Arie Spirgel, Rachel Goldman, Barbara J. Coffey

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 623-633

 

3 - Psychosocial Functioning and Health-Related Quality of Life in Children and Adolescents Treated with Open-Label Ziprasidone for Bipolar Mania, Schizophrenia, or Schizoaffective Disorder

Michelle Stewart, Melissa P. DelBello, Mark Versavel, David Keller

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 635-640

 

3 - Symptoms Leading to a Bipolar Diagnosis: A Phone Survey of Child and Adolescent Psychiatrists

Cathryn A. Galanter, Dana L. Pagar, Peter P. Oberg, Carrie Wong, Mark Davies, Peter S. Jensen

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 641-647

 

3 - Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study

Robert L. Findling, Lawrence D. Ginsberg, Rakesh Jain, Joseph Gao

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 649-662

 

5< - Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

Mary Solanto, Jeffrey Newcorn, Lucia Vail, Sharone Gilbert, Iliyan Ivanov, Regina Lara

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 663-671

 

3! - Predictive Factors for Persistent Use and Compliance of Immediate-Release Methylphenidate: A 36-Month Naturalistic Study

Paola Atzori, Tatiana Usala, Sara Carucci, Fabrice Danjou, Alessandro Zuddas

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 673-681

 

3 - Adverse Reactions to Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder: Structure and Associations with Clinical Characteristics and Symptom Control

Edmund J.S. Sonuga-Barke, David Coghill, Timothy Wigal, Marc DeBacker, James Swanson

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 683-690

 

4 - Measuring Methylphenidate Response in Attention-Deficit/Hyperactvity Disorder: How Are Laboratory Classroom-Based Measures Related to Parent Ratings?

Edmund J.S. Sonuga-Barke, David Coghill, Marc DeBacker, James Swanson

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 691-698

 

5< - Differential Effects of Atomoxetine on Executive Functioning and Lexical Decision in Attention-Deficit/Hyperactivity Disorder and Reading Disorder

Christien G.W. de Jong, Séverine Van De Voorde, Herbert Roeyers, Ruth Raymaekers, Albert J. Allen, Simone Knijff, Helene Verhelst, Alfons H. Temmink, Leo M.E. Smit, Rob Rodriques-Pereira, Dirk Vandenberghe, Inge van Welsen, Liesbeth ter Schuren, Mazim Al-Hakim, Azad Amin, Laurens Vlasveld, Jaap Oosterlaan, Joseph A. Sergeant

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 699-707

 

3 - Atomoxetine and Neuropsychological Function in Children With Attention-Deficit/Hyperactivity Disorder: Results of a Pilot Study

Michel Maziade, Nancie Rouleau, Bobbie Lee, Ann Rogers, Lori Davis, Ruth Dickson

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 709-718

 

3! - Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder

Linda A. Wietecha, David W. Williams, Michael Herbert, Raun D. Melmed, Michael Greenbaum, Kory Schuh

Journal of Child and Adolescent Psychopharmacology. December 2009, 19(6): 719-730

 

3! - Attention-Deficit Hyperactivity Disorder: Recent Advances in Paediatric Pharmacotherapy

May, Diane E; Kratochvil, Christopher J

Drugs: 1 January 2010 - Volume 70 - Issue 1 - pp 15-40

 

3 - Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?

Susan H. Busch, Richard G. Frank, Douglas L. Leslie, Andrés Martin, Robert A. Rosenheck, Erika G. Martin, and Colleen L. Barry

Psychiatr Serv 61:11-16, January 2010

 

.

Regresar a RESÚMENES DICIEMBRE 2009